Concepedia

Epidermal Growth Factor Receptor Mutations Are Associated with Docetaxel Sensitivity in Lung Cancer

Tatsuya Yoshimasu, Shoji Oura, Fuminori Ohta, Yoshimitsu Hirai, Koma Naito, Rie Nakamura, H Nishiguchi, Sayoko Hashimoto, Mitsumasa Kawago, Yoshitaka Okamura

Journal of Thoracic Oncology · 2011 · 16 citations · 20 references

DOIFull text

Open access

Concepts

References

20

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

Ken A. Olaussen, Ariane Dunant, Pierre Fouret et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text

Mutations of the Epidermal Growth Factor Receptor Gene Predict Prolonged Survival After Gefitinib Treatment in Patients With Non–Small-Cell Lung Cancer With Postoperative Recurrence

Tetsuya Mitsudomi, Takayuki Kosaka, Hideki Endoh et al. · Journal of Clinical Oncology · 2005 · 956 citations · Full text

Clinical applications of the histoculture drug response assay.

T Furukawa, Tetsuro Kubota, Robert M. Hoffman · PubMed · 1995 · 217 citations

, , +16

Expression of Class III β-Tubulin Is Predictive of Patient Outcome in Patients with Non–Small Cell Lung Cancer Receiving Vinorelbine-Based Chemotherapy

P. Sève, Sylvie Isaac, Olivier Trédan et al. · Clinical Cancer Research · 2005 · 196 citations

Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung Cancer

Craig H. Reynolds, Coleman K. Obasaju, Michael J. Schell et al. · Journal of Clinical Oncology · 2009 · 172 citations · Full text